drugset / Trial / NCT02411604
Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
Summary
Open label, multi-center, expanded access study for renal transplant patients with once daily Envarsus XR (Tacrolimus).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Tacrolimus | Small molecule | — | — |